$HP

HP Reports Strong Earnings, Stock Drops 10% Amid Demand Concerns

HP Inc. (NYSE: HP) reported Q3 revenue of $15.7B, up 13% YoY, and adjusted EPS of $0.83, beating expectations. Despite this, shares fell 10% due to concerns over demand and declining PC shipments. HP's P/S ratio is higher than its historical median, suggesting overvaluation. Insiders sold $5.24M in shares recently, indicating mixed sentiment.

Original reporting
Published Aug 27, 2026, 1:30 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 27, 2026, 10:21 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefEarnings
Primary signal
$HP
Bearish
high confidence
Mentioned
$HP
Relevance
8/10
alphai data visualization · based on gurufocus.com
Decision brief

The 30-second read

$HPBearishHigh
01

Why it matters

The earnings release introduced new revenue and EPS figures and modest guidance, triggering a 10% price decline.

02

Market read

Large‑cap tech stock with a significant same‑day move; traders should watch shipment trends and guidance updates.

03

What to watch

Rising memory chip costs and potential cost‑cutting measures could improve margins later in the year.

Relevance 8/10Novelty 8/10Timing: post‑earnings release

Background

HP is a $41.4B market‑cap technology company focused on PCs, printers, and services.

Company-level read

Ticker impact

$HPBearishHigh confidence
Context

HP reported Q3 earnings with revenue $15.7B and EPS $0.83, but the stock fell ~10% on demand concerns.

Expected impact

Expect further downside pressure if shipment declines persist; short‑bias in near term.

Evidence & confidence

The 10% drop reflects market reaction to weak shipment trends despite revenue growth; guidance only modestly above consensus.

Market effects

PC and printer segment weakness may pressure peers like Dell and Lenovo.

U.S. technology sector could see modest pullback.

Limited to hardware manufacturers; broader market impact minimal.

Counterpoint

Despite the drop, the price‑to‑sales ratio suggests limited upside, but the stock may be oversold if shipments rebound.

Key entities

  • HP Inc.

    Subject of the earnings report.

Related articles

$HPMedAI 8/10

Helmerich & Payne Q3 Earnings Call Highlights

Helmerich & Payne (NYSE:HP) reported Q3 call highlights. Management said super-spec fleet utilization is ~95%. For fiscal Q4, North America Solutions guidance is 145-151 rigs with direct margin of $245m-$255m, and full-year North American rig count raised to 140-144. International Solutions direct margin was $31m; Offshore was $29m. Company targets net debt/EBITDA of 1x and raised full-year Offshore direct margin to $113m-$117m.

$HPMed

Helmerich & Payne (NYSE:HP) Reports Upbeat Q2 CY2026

Helmerich & Payne (NYSE:HP) reported Q2 CY2026 results. Revenue was $1.03 billion, flat year on year but 5.4% above Wall Street estimates. GAAP profit was $0.74 per share, above analysts’ consensus. The article also cites adjusted EBITDA margin of 22.8% and notes the stock was about $33.59 after results.

$HPMed

Helmerich & Payne, Inc. (HP): Results of Operations and Financial Condition

Helmerich & Payne, Inc. (HP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 NEWS RELEASE August 5, 2026 HELMERICH & PAYNE, INC. ANNOUNCES FISCAL THIRD QUARTER RESULTS Operating and Financial Highlights for the Quarter Ended June 30, 2026 • H&P announced consolidated revenue of $1.035 billion, reflecting strong sequential growth and solid exe

$HPMedAI 8/10

BofA Raises its Price Target on Helmerich & Payne (HP)

On May 19, 2026, BofA analyst Saurabh Pant raised Helmerich & Payne’s (HP) price target to $44 from $41 and kept a Buy rating, citing updated oilfield services models after Q1 earnings and 10-Q filings. BofA said 2027 and 2028 EBITDA forecasts are about 10% and 16% above consensus. Piper Sandler raised its target to $43 from $41 with an Overweight rating.